More good news in the pursuit of a COVID-19 vaccine: A fifth vaccine developer has released promising results from a small, early trial.
Novavax Inc., of Gaithersburg, Maryland, released the results via a news release and call with media late Tuesday, showing the vaccine appeared safe and elicited a similar immune response to an active infection with COVID-19.
"Good news," said Dr. William Schaffner, a...